suvorexant 5 MG Oral Tablet Belsomra
1 INDICATIONS AND USAGE BELSOMRA ® (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. BELSOMRA is an orexin receptor antagonist indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance ( 1 ).
merck sharp & dohme corp.
ROUND YELLOW 5
Related Pills
belsomra tablet film coated
merck sharp & dohme corp.
suvorexant 20 MG Oral Tablet Belsomra
merck sharp & dohme corp.
suvorexant 10 MG Oral Tablet Belsomra
merck sharp & dohme corp.
belsomra suvorexant tablet film coated
merck sharp & dohme corp.
bisacodyl 5 mg
Major Pharmaceuticals
donepezil 5 mg
torrent pharmaceuticals limited
lisinopril tablet
Lupin Pharmaceuticals, Inc.
meloxicam 7.5 mg
carlsbad technology, inc.
Acetaminophen 650 mg Hydrocodone 10 mg
watson laboratories, inc.
desloratadine 5 mg oral tablet
virtus pharmaceuticals
BZP hydrochloride 5 MG Oral Tablet
Eon Labs, Inc.
APAP 500 MG Oral Capsule
Geri-Care Pharmaceutical Corp
ranitidine 150 MG as ranitidine hydrochloride 168 MG Oral Tablet
Dr. Reddy's Laboratories Limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied BELSOMRA tablets, 5 mg, are yellow, round, film-coated tablets, with "5" on one side and plain on the other side. They are supplied as follows: NDC 0006-0005-30 unit-of-use blisters of 30 BELSOMRA tablets, 10 mg, are green, round, film-coated tablets, with "33" on one side and plain on the other side. They are supplied as follows: NDC 0006-0033-30 unit-of-use blisters of 30 BELSOMRA tablets, 15 mg, are white, oval, film-coated tablets with the Merck logo on one side and "325" on the other side. They are supplied as follows: NDC 0006-0325-30 unit-of-use blisters of 30 BELSOMRA tablets, 20 mg, are white, round, film-coated tablets with the Merck logo and "335" on one side and plain on the other side. They are supplied as follows: NDC 0006-0335-30 unit-of-use blisters of 30 16.2 Storage and Handling Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F), [see USP Controlled Room Temperature]. Store in the original package until use to protect from light and moisture.
More pills like ROUND 5